Discovery Platform
From Target to Market

Discovery Services

Proven Chemistry

Screening Libraries
1.6M Compounds eShop

Pharmaceutical
Development

Pharmaceutical Development

Why Choose ChemDiv?

  • 25 years experience and 2500 customers worldwide
  • Premium R&D CRO based in USA with global reach
  • Seasoned project managers
  • Extensive Academic partnerships
  • Flexible business models
  • Industry's largest ever-greening stock compound inventory
  • Ongoing investments in novel proprietary chemistry and discovery platforms
Learn More About Us

Our News

Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer
Israel’s Healthy.io raises $60 million, gets FDA ok for urine test
Purdue inks multibillion-dollar opioid deal with thousands of local governments, more than 20 states: reports
Read All Our News >

Pharma News

Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer
Israel’s Healthy.io raises $60 million, gets FDA ok for urine test
Purdue inks multibillion-dollar opioid deal with thousands of local governments, more than 20 states: reports
Read All Pharma News >

New Products &Services

Target Activity profiling library
MCE-18 Trends in MedChem
Covalent Inhibitors library
RNA Trinucleotide mimetics
Share this: